Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia

Leukemia

Volumn 25, Issue 2, 2011, Pages 367-371

  Yu, L ^a   Reader, J C ^a   Chen, C ^a   Zhao, X F ^a   Ha, J S ^b   Lee, C ^b   York, T ^a   Gojo, I ^a   Baer, M R ^a   Ning, Y ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD7 ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR RECEPTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG; ZDHHC14 PROTEIN;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; CASE REPORT; CHILD; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; KARYOTYPING; LETTER; LEUKEMIA CELL LINE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

EID: 79751532529     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.271     Document Type: Letter

References (8)

1. Saglio G, Guerrasio A, Rosso C, Zaccaria A, Tassinari A, Serra A et al. New type of Bcr/Abl junction in Philadelphia chromosomepositive chronic myelogenous leukemia. Blood 1990; 76: 1819-1824.
2. Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996; 88: 2410-2414. (Pubitemid 26327488)
3. Pane F, Intrieri M, Quintarelli C, Izzo B, Muccioli GC, Salvatore F. BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene 2002; 21: 8652-8667. (Pubitemid 36084197)
4. Oshikawa G, Kurosu T, Arai A, Murakami N, Miura O. Clonal evolution with double Ph followed by tetraploidy in imatinibtreated chronic myeloid leukemia with e19a2 transcript in transformation. Cancer Genet Cytogenet 2010; 199: 56-61.
5. Lee S, Kim YJ, Min CK, Kim HJ, Eom KS, Kim DW et al. The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 2005; 105: 3449-3457. (Pubitemid 40628185)
6. Lee JJ, Kim HJ, Kim YJ, Lee S, Hwang JY, Kim YL et al. Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts. Leukemia 2004; 18: 1539-1540. (Pubitemid 39264077)
7. Bennour A, Beaufils N, Sennana H, Meddeb B, Saad A, Gabert J. E355G mutation appearing in a patient with e19a2 chronic myeloid leukaemia resistant to imatinib. J Clin Pathol 2010; 63: 737-740.
8. Popovici C, Charbonnier A, Gisserot O, Aguilon P, Rémy V, Olschwang S et al. Y253H mutation appearing in a micro-BCR-ABL (e19a2) CML. Leuk Res 2008; 32: 361-362. (Pubitemid 351215527)